Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse

Defining the role of high-dose therapy with autologous stem cell rescue in the therapeutic algorithm of follicular lymphoma remains a major challenge. In contrast to the acknowledged poor outcome associated with cyclophosphamide/total body irradiation conditioning in heavily pretreated patients, the...

Full description

Bibliographic Details
Published in:Haematologica
Main Authors: Silvia Montoto, Janet Matthews, Paul Greaves, Debra Lillington, Deborah Anderson, John G. Gribben, T. Andrew Lister
Format: Article
Language:English
Published: Ferrata Storti Foundation 2013-04-01
Online Access:https://haematologica.org/article/view/6633